Elemene
- Generic Name
- Elemene
- Indication
合并放、化疗对肺癌、肝癌、食管癌、鼻咽癌、脑瘤、骨转移癌等可以增强疗效，降低放、化疗的毒副反应；可用于介入、腔内化疗及癌性胸腹水的治疗。
Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma
- Conditions
- Glioblastoma, IDH-wildtype
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 74
- Registration Number
- NCT05842746
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2020-12-19
- Lead Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Target Recruit Count
- 30
- Registration Number
- NCT04674527
- Locations
- 🇨🇳
Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study
- Conditions
- CarcinomaNon-Small-Cell Lung CancerAdenocarcinoma
- Interventions
- Drug: First or third generation EGFR-TKIs
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- Tian Xie
- Target Recruit Count
- 744
- Registration Number
- NCT04401059
- Locations
- 🇨🇳
The Second People's Hospital of Yangcheng County, Jincheng, Shanxi, China
🇨🇳Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China
🇨🇳Sichuan Academy of Medical Sciences· Sichuan Province People's Hospital, Chengdu, Sichuan, China
Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer
- Conditions
- Advanced Primary Liver Cancer
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03167775
- Locations
- 🇨🇳
Henan Medical University Cancer Hospital, Zhengzhou, Henan, China
Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03166553
- Locations
- 🇨🇳
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
🇨🇳Jinan Military General Hospital, Jinan, Shandong, China
🇨🇳Henan Medical University Cancer Hospital, Zhengzhou, Henan, China
β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Drug: EGFR-TKIs(Erlotinib, Gefitinib and Icotinib)
- First Posted Date
- 2017-04-21
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- China Medical University, China
- Target Recruit Count
- 80
- Registration Number
- NCT03123484
A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas
- Conditions
- Anaplastic OligoastrocytomaAnaplastic AstrocytomaGlioblastoma
- Interventions
- First Posted Date
- 2015-12-14
- Last Posted Date
- 2018-02-23
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 100
- Registration Number
- NCT02629757
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.